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Abstract 
Evidence is increasing about an unsatisfying performance 
from the existing non-disease-specific scoring systems in the 
intensive care unit (ICU). Evidence is furthermore increasing 
about differences in the mortality rate between diabetics and 
non-diabetics dependent on the level of blood glucose (BG), 
but few scoring systems include these variables in the as-
sessment of the patients. 142,404 ICU admissions were in-
cluded from the eICU database in the development of an un-
supervised trained Bayesian Network (BN). The BN suggest-
ed that abnormalities in the level of BG should be associated 
with differences in the mortality rate between diabetics and 
non-diabetics. The BN showed promising predictive ability 
with an AUC on 0.86 for predicting death (sensitivity: 75.06, 
specificity: 78.40 %). 48.43 % of the length of stays (LOS) 
were correctly predicted. The results were slightly below the 
results from the APACHE IV scoring system but showed 
great ability of risk stratification. The BN showed a potential 
for predicting the patient outcome and might enable an im-
proved method for risk stratifying the patients admitted to the 
ICU. 
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Introduction 
The ICU is a preventive and therapeutic care setting that take 
care of patients who suffers from a very vulnerable and po-
tential reversible failure of the organ systems that is more 
severe and beyond a treatable limit from a regular bed de-
partment [1] [2]. The immune system of the patients at the 
ICU is often at a worsened state [1]. The ICU includes ob-
servation, diagnosis, treatment and caretaking of the patient 
[2]. 
 
In the last century has the ICU been under a rapidly devel-
opment, including a development of multiple scoring systems 
[3]. Most of the different scoring systems includes a score – 
an integer – and a probability model, which predict the mor-
tality rate for the patient [3].  
 
Most of the existing scoring systems are developed to evalu-
ate general disease severity for a mixed patient group in the 
ICU [4]. Some studies suggest, that the accuracy of the mod-
els is sufficient when evaluating a mixed group of critical ill 
patient admitted to the ICU [5] [6]. On the other hand, is the 
evidence also increasing about the models performs insuffi-
cient related to disease specific complications, such as Cardi-
ac Arrest, H1N1 (influenza A), Acute Respiratory Distress 
Syndrome and patients requiring respiratory support [7] [8] 
[9] [10] [11]. This might support the discussion of whether 
the old models developed for evaluating general disease se-
verity is suited for evaluating specific disease severity in the 
ICU [4].  
 
A disease-specific patient group, meeting an increased inter-
est in the ICU, is the patients suffering from Diabetes Melli-
tus (DM), where abnormalities in the level of BG are report-
ed to have different impact on the mortality rate dependent 
on whether the patient suffers from DM [12] [13]. DM is the 
seventh most common cause of death in USA and is further-
more related to other comorbidities, such as retinopathy, neu-
ropathy, renal failure, coagulative- and cardiovascular com-
plications [14]. Although, the actual impact from DM, and 
the underlying mechanisms, on both the severity of the con-
dition and the mortality rate not fully understood [15]. It 
might therefore be essential develop a model that enables an 
analysis of correlations between changes in multiple varia-
bles for the patients with DM. The disease-specific scoring 
system for diabetics should additionally be able to analyze 
the joint probability of DM and the level of BG in the ICU to 
improve the understanding of how patients suffering from 
DM proceeds in the ICU compared to non-diabetics.  
 
The objective of this paper was therefore to develop a new 
model for decision support and risk stratification of patients 
suffering from DM admitted to the ICU. The model should 
enable an assessment of the impact from a joint probability 
of DM and the level of BG and furthermore seek to improve 
the accuracy of the predictions regarding mortality rate and 
LOS, compared to the APACHE IV scoring system. 
Materials and Methods 
The data acquired was collected from 2014-2015 and con-
tains data about critical ill patients admitted to the ICU in 
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USA. Data was collected in the eICU Collaborative Data-
base. The eICU Collaborative Database included data from > 
200,000 patient admissions. The mean age of all the patients 
was 61.97 years, 45,90 % was female and 54.10 % was male.  
 
Data screening 
142,404 ICU admissions were registered with information of 
whether the patients suffered from DM and an actual mortali-
ty rate and an actual LOS. Admissions with missing infor-
mation regarding DM, mortality rate and LOS were exclud-
ed. 108,899 admissions were registered without DM and 
33,505 admissions registered with diabetes. There was no 
discrimination between Type 1 Diabetes Mellitus (T1DM) 
and Type 2 Diabetes Mellitus (T2DM) in the eICU database. 
4.93 % of the patients suffering from DM died in the hospital 
and 6.17 % of the patients without DM died in the hospital. 
 
Bayesian Network 
A BN was used as it enabled an assessment of correlations in 
data, including analyzing the joint probability of two or more 
variables in the ICU. BN’s used the Bayesian rule to update 
the probability of each node when evidence  was presented. 
The Bayesian rule stated: 
 
           (1) 
Which was that the probability of having the disease given 
symptoms, , could be calculated if the probability of 
having the symptoms, , the probability of having the 
disease, , and the probability of having the symptoms, 
, were known. 
 
When evidence was presented in the network, would the 
probabilities be updated dependent on how the connections in 
the network was modelled. This concept was called probabil-
istic inference. The probabilistic inference was used for rea-
soning in the network. The Bayesian rule can be rewritten as 
[16]: 
 
 
  
    (2) 
 
 
This indicated, that the probability of having the disease given 
symptoms, , had a proportional dependency on the 
children nodes, , and the parent nodes, . [16]  
Information could not flow between children nodes in a BN, 
which instead was written as the product of all the likelihoods, 
.  represented the j ’th child note,  repre-
sented the value of the probabilities of cardinality it states. 
 represented the value of the state n on the parent node . 
All priors were summarized and multiplied by their condition 
probability, . The children 
nodes and the parent nodes were normalized to get exactly 
. [16]  
 
The Bayesian rule and the probabilistic inference were used to 
let information pass though the network and predict how evi-
dence affect the probabilistic outcome throughout the entire 
network [16]. This means that a quantification of the condi-
tion, a risk stratification and a predicted score for mortality 
rate and LOS could be calculated dependent on entered evi-
dence  in the BN. 
 
Structure learning 
The development of the graphical structure of the BN was 
performed in Hugin Expert Developer 
(https://www.hugin.com/). Structure learning was performed 
unsupervised using the Greedy Search-and-score algorithm 
provided by Hugin Expert. A maximum of 13 parents were 
chosen in the Greedy Search-and-score algorithm for the BN 
and Bayesian Information Criterion (BIC) was chosen as the 
penalized likelihood criteria. BIC penalizes the complexity of 
the model and rewards the model if it fits the data well. [17] 
 
Parameter learning 
The distributions of data-points between the states in each 
node – the parameters – were learned by using the Expecta-
tion-Maximization (EM) algorithm. The EM algorithm hand-
led missing data very well, making it suited for handling re-
al-life data. The EM-algorithm was furthermore considered 
as the natural choice of algorithm for parameter learning if 
the structure learning was performed by the Greedy Search-
and-Score algorithm [18]. The EM-algorithm counts the pa-
rameter for the BN. 
 
Validation 
The holdout method was used for validation, which separated 
the dataset into a training set and a test set [19]. The data was 
distributed as 90 % for training and 10 % for test. This meth-
od ensures that the model was less likely to be overfitted.  
 
The accuracy of the predictions from the BN was compared 
with the predictions from the APACHE IV scoring system. 
Two APACHE IV models were developed for the test: one 
for mortality and one for LOS. The two APACHE IV models 
were illustrated in Figure 1. 
Figure 1 – Presented the two models for testing the accuracy 
of the predictions from APACHE IV 
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The same unique patientunitstayID was used for both testing 
the BN and the APACHE IV scoring system. 128,164 admis-
sions were used for training and 14,240 admissions were used 
for testing. 
Results 
Three tests were performed for the BN: (1) One for testing 
the impact of a joint probability of DM and the level of BG 
on the mortality rate, (2) one for testing the performance of 
predicting the mortality rate and (3) One for testing the per-
formance of predicting the LOS. 
 
The impact from DM and level of BG on the mortality 
rate  
 
Figure 2 illustrates the impact on the mortality rate from a 
joint probability of the level of BG and respectively diabetics 
and non-diabetics. 
 
Figure 2 – presented the correlation between mortality rate 
and the joint probability of the level of BG and diabetes. 72 – 
180 mg/dL was associated with a normal level of BG 
 
Performance test for predicting mortality rate 
A performance test was also carried out to evaluate the accu-
racy of the predictions from the BN regarding the mortality 
rate for both diabetics and non-diabetics, which were also 
compared with a performance test for the APACHE IV scor-
ing system. The performance test consisted of a ROC-curve 
with an associated AUC, and a result table which illustrated 
the relationship from different cut-offs between sensitivity 
and specificity. The ROC-curve for predicting mortality for 
both diabetics and non-diabetics were a test of the accuracy 
of predicting the [mortality: dead]. The ROC-curve was pre-
sented in Figure 3: 
 
 
Figure 3 – Presented the ROC-curve of [mortality: dead] 
with an AUC on 0.85561. The ROC-curve illustrates sensitiv-
ity (true positive rate) vs. 1 – specificity (false positive rate) 
 
The ROC-curve had an AUC on 0.86 for the BN developed 
in this project. In comparison did the test of APACHE IV 
show an AUC on 0.87 for [Mortality: Dead], which was test-
ed following Figure 1.  
 
Different cut-offs could be chosen for sensitivity and speci-
ficity for the BN developed in this project. A moderate sensi-
tivity and a moderate specificity also calculated because a 
high sensitivity caused a low specificity and a high specifici-
ty caused a low sensitivity. The relationship between sensi-
tivity and specificity were presented in a result table, which 
was presented in Table 1: 
 
Table 1 – Presented the relationship between sensitivity and 
specificity in terms of number of true positive (No. TP), num-
ber of false positive (No. FP), number of true negative (No. 
TN) and number of false negative (No. FN). 
 
The APACHE IV scoring system had a moderate sensitivity 
on 75.57 % and a moderate specificity on 81.07 %. 
 
Performance test for predicting LOS 
The performance test of predicting LOS consisted of a confu-
sion matrix, where predictions was from a max belief and a 
 
 
Sensi
tivity 
Speci
ficity 
No. 
TP 
No. 
FP 
No. 
TN 
No. 
FN 
High  
Sensitivity 
100.0
0 % 
0.12 
% 
12416  823 1 0 
High 
Specificity 
2.71 
% 
100.0
0 % 
364 0 824 13052 
Moderate 
Specificity 
75.06 
% 
78.40 
% 
10070 178 646 3346 
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calculation of the percentage of correct predictions. The con-
fusion matrix for LOS was illustrated in Table 4: 
 
Table 2 – Presented the confusion matrix of LOS 
 
< 1. 
(actual) 
1. – 2. 
(actual) 
> 2. 
(actual) 
 
808 608 425 < 1. 
(predict-
ed) 
1640 1754 1442 1. – 2. 
(predict-
ed) 
1215 2029 4318 > 2. 
(predict-
ed) 
 
48.43 % were correctly predicted from a test of max belief. 
In comparison did the test of APACHE IV show that 52.54 % 
was correctly predicted from a test of max belief, which was 
tested following Figure 1. 
Discussion 
An AUC > 0.80 was associated with good discrimination 
capability [5], meaning the accuracy of predicting the mortal-
ity rate was considered satisfying for the BN even though the 
accuracy of the predictions from the BN was slightly below 
the predictions from the APACHE IV scoring system. The 
accuracy of predicting the LOS was considered satisfying, 
because the test was performed as a test of max belief, 
whereas the actual prediction from the BN was a distribution 
of likelihoods. The accuracy from the test of max belief of 
the prediction of LOS was slightly below the predictions 
from the APACHE IV scoring system. 
The literature suggested that the non-diabetics was more vul-
nerable towards hyperglycemia and hypoglycemia [12, 13] 
which was also suggested by the BN. The increased mortality 
for non-diabetics with abnormalities in the level of BG might 
be explained by the diabetics are more accustomed towards 
both hyperglycemia and hypoglycemia [15].  
It was possible that the mortality would be different for 
T1DM and T2DM, where e.g. the body mass index of espe-
cially T2DM could have an impact on the mortality rate [15]. 
Hba1c could also be a part of the assessment of the patient, 
which could explain occurrence of abnormalities in the level 
of BG prior to ICU admission or even cases of unknown DM 
[14]. This might affect the degree of how accustomed the 
patient was to experiencing abnormalities in the level of BG. 
Intensive insulin treatment could also be within the scope of 
assessing diabetics in the ICU, as the mortality rate and LOS 
might be dependent on the intensive insulin treatment [20] 
and because the intensive insulin treatment was strongly as-
sociated with normal DM caretaking [21, 22]. 
The Greedy Search-and-score algorithm was used for struc-
ture learning, but other algorithms exist for unsupervised 
structure learning. The PC-approach makes edges between 
all nodes with no conditional independence in the BN [18], 
meaning a very complex BN will be generated with very 
high number of CPT’s, which would be practically impossi-
ble to compile for a BN with many nodes and states. This 
could be solved by inspecting the model and deleting some 
of the edges, which might hold the potential of ensuring all 
edges associated with domain knowledge were included in 
the model. It would be interesting for a future study to evalu-
ate whether the PC-approach could improve the accuracy of 
the predictions, as an alternative structure of the BN could be 
produced [18]. The Rebane-Pearl might hold the potential for 
improving the transparency of the model, where edges were 
directed away from a root where one node could only have 
one parent (except for the root-node) [18]. The Rebane-Pearl 
algorithm was not used for unsupervised structure learning, 
as one patient could have more diagnoses and one variable 
for APS was associated with other APS variables for the 
same organ system, meaning one node was expected to have 
multipleparents.  
The Greedy Search-and-Score algorithm was considered 
suited for weighting the accuracy and transparency, where an 
inspection of the generated structure for a disease-specific 
model for DM showed promising edges. The Greedy-search-
and-Score did also show a promising accuracy of the predic-
tions, meaning the algorithm was considered as a promising 
approach for performing unsupervised structure learning. 
Conclusion 
The output of this paper was a BN developed through unsu-
pervised structure learning (by the Greedy Search-and-score 
algorithm) and parameter learning (by the EM algorithm). 
The BN was able to quantify the severity of the condition, 
predict the outcome for the patient and potentially improve 
the risk stratification of the patient admitted to the ICU. The 
BN could possibly be a means for decision support for the 
clinician when evaluating patients suffering from DM admit-
ted to the ICU.  
The results showed high difference in the likelihood for mor-
tality rate for the joint probability of DM and the level of 
BG.  
Both the BN and the APACHE IV scoring system showed 
high accuracy in predicting the mortality rate and relatively 
poor accuracy of predicting the LOS, though predicting LOS 
for both the BN and the APACHE IV scoring system were 
better than just guessing. The accuracy of the predictions of 
mortality rate and LOS from the BN was slightly below the 
accuracy of the predictions from the APACHE IV scoring 
system. The BN was associated with an improved and alter-
native method for risk stratification where the BN was able 
to present changes in the likelihood from correlations be-
tween evidence in multiple variables for both diabetics and 
non-diabetics in the ICU. 
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